ANZ (ASX:ANZ) recently announced a quarterly total provision charge of A$77 million.

In the same quarter, ANZ (ASX:ANZ) experienced a slight increase in gross impaired assets as a percentage of total gross loans and advances, rising from 17 basis points to 18 basis points.

During the same period, both the Australia retail and Australia commercial net loans and advances, including housing, grew by 2%.

At the end of the quarter, Australian housing more than 90 days past due measured at 63 basis points, a rise of 3 basis points.

Additionally, total exposure at default declined by 3% during the quarter, marked by a A$34 billion decrease in lower risk intensive sovereigns and financial institutions RWA.

ANZ (ASX:ANZ) is an Australian multinational banking and financial services company.

Citi analysts have reduced their price target on Australia’s Core Lithium (ASX:CXO) to A$0.40 per share, down from A$0.40 per share, maintaining a ‘sell’ rating.

The company announced plans on Wednesday to raise around A$100 million to A$120 million in funds, representing a 27% discount.

This timing of the equity raising surprised Citi, which also questioned the convictions pertaining to the performance of Core Lithium’s Finniss lithium project.

The downgrade in price target arrived after Citi updated their model valuation estimates, having noticed that Core Lithium was encountering more ramp-up challenges compared to other lithium producers.

They have projected an EPS dilution in FY24 of 12% and 13% in FY25.

As of the most recent closing, the stock had fallen 46.8% this year.

Core Lithium (ASX:CXO) is an Australia-based company specializing in lithium production projects.

Telstra Group (ASX:TLS) has declared a total final dividend of 8.5 AU cents per share.

The company anticipates its total income for fiscal 2024 to range from A$22.8 billion to A$24.8 billion.

Fiscal year profit is reported to be A$1928 million compared to A$1,688 million of the previous year.

Underlying EBITDA for the fiscal year of 2024 is estimated to be between A$8.2 billion and A$8.4 billion.

The company also forecasts a capex of A$3.6 billion to A$3.7 billion and free cash flow after lease payments between A$2.8 billion and A$3.2 billion.

The company has expressed a commitment towards its FY25 underlying EBITDA and EPS growth ambitions, planning to increase revenues and improve operating efficiency in the fiscal year of 2024.

The total income for the fiscal year is reported to be A$23245 million in comparison to A$22,045 million last year.

Telstra Group (ASX:TLS) is determined to meet its FY25 underlying EBITDA and EPS growth objectives.

The company acknowledges the risk related to its goal of reducing absolute scope 3 greenhouse gas emissions by at least 50% by 2030.

In the coming year, the company plans to reach the midpoint of its T25 strategy and continue to deliver its T25 objectives for FY24.

Telstra Group (ASX:TLS) is a leading Australian telecommunications and technology company offering a range of services including mobile and internet connections, and broadband.

Citi analysts predict a series of catalysts that could potentially drive earnings growth for Australian property developer, Mirvac Group (ASX:MGR), starting from financial year 2025.

The brokerage boosts the target price (PT) to A$2.50 per share, up from A$2.40, while still maintaining a ‘neutral’ stance.

The analysts foresee a dip in costs related to debts and an anticipated improvement in the master plan communities business volumes.

Out of 14 analysts, two rated Mirvac Group’s stock a ‘buy’, nine ‘neutral’, and three a ‘sell’ or lower.

Their median target price is A$2.32, according to Refinitiv data.

As of the recent closing, the stock’s performance has seen a 12.7% surge this year.

Mirvac Group is a leading Australian property developer with core operation in the creation of residential, retail, office, industrial, and mixed-use properties.

Seven Group Holdings (ASX:SVW) has released its outlook for segments and group-level guidance for the financial year 2024.

The company is expecting high single-digit EBIT growth in FY24, supported by various factors across its operations.

Within the Industrial Services segment, elements such as an aging mining fleet and the production outlook for bulk commodity are expected to underpin the support opportunity for WesTrac.

Seven Group Holdings is expressing a determined focus on continuing its growth into the financial year 2024.

Seven Group Holdings is a diversified company with interests in industrial services, media, and investments.

Citi analysts predict Solid Year 2024 for Australia’s Netwealth Group (ASX:NWL), following the wealth manager’s net profit after tax, with a growth of 20% in Fiscal Year 2023.

The brokerage has increased its stock price target from A$14/share to A$14.45/share, maintaining its neutral position.

Citi anticipates the company will see about 29% EPS growth in Fiscal Year 2024.

The company’s net flows are expected to rise and margins are projected to expand owing to the slowing growth in operating expenses.

Among the 14 analysts, four rate the stock as buy or higher, six hold it, and four rate it as sell or lower; the median price target is A$14.25 according to Refinitiv.

The stock saw an increase of 19.9% this year, as of the previous closing.

Netwealth Group is a well-known wealth manager based in Australia.

Seven Group Holdings announced a Fiscal Year net profit attributable of A$596.6 Million, marking a 6.8% increase.

A significant rise of 20.1% was also reported in their revenue from ordinary activities, from continuing operations, taking it to A$9,626.5 Million.

Furthermore, they have declared a final dividend of 23 Australian cents per share.

Seven Group (ASX:SVW) is a diversified operating and investment company with businesses and investments in industrial services, oil and gas production, and media.

Analysts from Canaccord Genuity lower their price target on Lifestyle Communities (ASX:LIC), an Australian retirement and aged care provider, from A$17.10/share to A$17/share.

The company recently announced a total of 356 settlements for fiscal 2023, declining from 401 in the previous fiscal year.

Further revisions from the brokerage have downgraded estimates for new home settlements on the company to 475 from 515 for FY24 and to 600 from 643 for FY25.

Additionally, Canaccord has revised underlying net profit after tax expectations by 9% and 14% for FY24 and FY25, respectively.

On Wednesday, Lifestyle Communities fell as much as 12% before recovering some of its losses, and ultimately ending the day 4.3% lower.

So far this year, the stock has depreciated by 12.5%.

Lifestyle Communities is a firm specializing in retirement and aged care services in Australia.

Despite challenging macroeconomic conditions, and a supply-demand imbalance in the wider Australian office market, Dexus (ASX:DXS), has succeeded in maintaining lofty occupancy ratios and a relatively cautious balance sheet, reports Citi.

This comes even as the real estate company reels from its first net loss since 2009, with soaring interest rates erasing almost A$1.2 billion (equivalent to $770.88 million) from the value of its property assets.

Citi modifies its fiscal year 2024 and 2025 Earnings Per Share (EPS) predictions by respective increases of 4% and 2.2%, permitting room for stronger funds management income.

The firm elevates its price target to A$8.20 from A$8.00 while keeping the stock rating ‘neutral.’ Notwithstanding wariness surrounding the vulnerable supply demand dynamics in the Australian office market, Dexus is deemed to have outlive this subsector operationally, according to the brokerage.

Analysts' assessments of the stock are varied: 5 of 11 analysts place the stock at ‘buy’ or higher, 4 say ‘hold’ and 2 consider it a ‘sell’; the median price target stands at A$8.90 according to Refinitiv data.

This year, up until the last closing, Dexus (ASX:DXS)’s stock has risen by 0.1%.

Dexus (ASX:DXS) is an Australian real estate company that manages a high-quality Australian property portfolio valued at $32.1 billion.

Shares of Precision BioSciences (ASX:DTIL) slipped by 8.5%, reaching a record low of $0.49.

The plunge comes after the biopharmaceutical company completed a transaction for the global rights of its leading cancer therapy with Imugene.

As part of the agreement, Precision BioSciences (ASX:DTIL) is set to receive $227 million in upfront and milestone payments.

The upfront cash combined with decreased operating expenses is expected to extend the firm’s cash runway to the third quarter of 2025.

Precision BioSciences (ASX:DTIL) experienced stock disruption as it made a business pivot, resulting in an exit from the company that had been closely associated with the development of CAR-T cancer therapy.

The news of the transaction contributed to this disruption, as noted by BTIG analyst Justin Zelin.

Accounting for the session losses, the stock has plummeted roughly 59% YTD.

Precision BioSciences is a biopharmaceutical company that focuses on pioneering genome editing technologies.